S&P 500   3,351.28 (+0.06%)
DOW   27,433.48 (+0.17%)
QQQ   271.47 (-1.15%)
AAPL   444.45 (-2.45%)
MSFT   212.48 (-1.79%)
FB   268.44 (+1.19%)
GOOGL   1,498.37 (-0.44%)
AMZN   3,167.46 (-1.78%)
NVDA   447.98 (-1.20%)
CGC   16.63 (-5.08%)
BABA   252.10 (-5.11%)
TSLA   1,452.71 (-2.48%)
MU   48.75 (+0.10%)
GE   6.40 (+1.11%)
AMD   84.85 (-2.15%)
T   30.02 (+0.60%)
F   6.86 (-1.01%)
ACB   10.27 (-0.39%)
GILD   69.35 (+0.78%)
NFLX   494.73 (-2.82%)
DIS   129.93 (-0.68%)
BAC   26.11 (+2.51%)
BA   170.02 (-1.27%)
S&P 500   3,351.28 (+0.06%)
DOW   27,433.48 (+0.17%)
QQQ   271.47 (-1.15%)
AAPL   444.45 (-2.45%)
MSFT   212.48 (-1.79%)
FB   268.44 (+1.19%)
GOOGL   1,498.37 (-0.44%)
AMZN   3,167.46 (-1.78%)
NVDA   447.98 (-1.20%)
CGC   16.63 (-5.08%)
BABA   252.10 (-5.11%)
TSLA   1,452.71 (-2.48%)
MU   48.75 (+0.10%)
GE   6.40 (+1.11%)
AMD   84.85 (-2.15%)
T   30.02 (+0.60%)
F   6.86 (-1.01%)
ACB   10.27 (-0.39%)
GILD   69.35 (+0.78%)
NFLX   494.73 (-2.82%)
DIS   129.93 (-0.68%)
BAC   26.11 (+2.51%)
BA   170.02 (-1.27%)
S&P 500   3,351.28 (+0.06%)
DOW   27,433.48 (+0.17%)
QQQ   271.47 (-1.15%)
AAPL   444.45 (-2.45%)
MSFT   212.48 (-1.79%)
FB   268.44 (+1.19%)
GOOGL   1,498.37 (-0.44%)
AMZN   3,167.46 (-1.78%)
NVDA   447.98 (-1.20%)
CGC   16.63 (-5.08%)
BABA   252.10 (-5.11%)
TSLA   1,452.71 (-2.48%)
MU   48.75 (+0.10%)
GE   6.40 (+1.11%)
AMD   84.85 (-2.15%)
T   30.02 (+0.60%)
F   6.86 (-1.01%)
ACB   10.27 (-0.39%)
GILD   69.35 (+0.78%)
NFLX   494.73 (-2.82%)
DIS   129.93 (-0.68%)
BAC   26.11 (+2.51%)
BA   170.02 (-1.27%)
S&P 500   3,351.28 (+0.06%)
DOW   27,433.48 (+0.17%)
QQQ   271.47 (-1.15%)
AAPL   444.45 (-2.45%)
MSFT   212.48 (-1.79%)
FB   268.44 (+1.19%)
GOOGL   1,498.37 (-0.44%)
AMZN   3,167.46 (-1.78%)
NVDA   447.98 (-1.20%)
CGC   16.63 (-5.08%)
BABA   252.10 (-5.11%)
TSLA   1,452.71 (-2.48%)
MU   48.75 (+0.10%)
GE   6.40 (+1.11%)
AMD   84.85 (-2.15%)
T   30.02 (+0.60%)
F   6.86 (-1.01%)
ACB   10.27 (-0.39%)
GILD   69.35 (+0.78%)
NFLX   494.73 (-2.82%)
DIS   129.93 (-0.68%)
BAC   26.11 (+2.51%)
BA   170.02 (-1.27%)
Log in

NASDAQ:PETSPetmed Express Stock Price, Forecast & News

$31.88
+0.26 (+0.82 %)
(As of 08/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$31.35
Now: $31.88
$32.40
50-Day Range
$30.73
MA: $35.04
$40.53
52-Week Range
$15.12
Now: $31.88
$42.88
Volume682,652 shs
Average Volume684,690 shs
Market Capitalization$646.27 million
P/E Ratio22.61
Dividend Yield3.54%
Beta0.64
PetMed Express, Inc. and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes. It also sells food, beds, crates, stairs, strollers, and other pet supplies. The company sells its products through its Internet Website; telephone contact center; and direct mail/print through brochures and postcards. PetMed Express, Inc. was founded in 1996 and is headquartered in Delray Beach, Florida.
Read More
Petmed Express logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.0Community Rank: 1.5Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.16 out of 5 stars


Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryInternet Retail
Current SymbolNASDAQ:PETS
CUSIP71638210
Phone561-526-4444

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$284.13 million
Cash Flow$1.40 per share
Book Value$6.55 per share

Profitability

Net Income$25.85 million

Miscellaneous

Employees187
Market Cap$646.27 million
Next Earnings Date10/19/2020 (Estimated)
OptionableOptionable
$31.88
+0.26 (+0.82 %)
(As of 08/7/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PETS News and Ratings via Email

Sign-up to receive the latest news and ratings for PETS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Petmed Express (NASDAQ:PETS) Frequently Asked Questions

How has Petmed Express' stock been impacted by COVID-19 (Coronavirus)?

Petmed Express' stock was trading at $25.95 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, PETS stock has increased by 22.9% and is now trading at $31.88.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Petmed Express?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Petmed Express in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Petmed Express
.

When is Petmed Express' next earnings date?

Petmed Express is scheduled to release its next quarterly earnings announcement on Monday, October 19th 2020.
View our earnings forecast for Petmed Express
.

How were Petmed Express' earnings last quarter?

Petmed Express Inc (NASDAQ:PETS) issued its earnings results on Monday, July, 20th. The company reported $0.39 earnings per share for the quarter, missing analysts' consensus estimates of $0.40 by $0.01. The business earned $96.20 million during the quarter, compared to the consensus estimate of $90.96 million. Petmed Express had a net margin of 9.41% and a return on equity of 21.91%. The company's quarterly revenue was up 20.3% compared to the same quarter last year. During the same period in the previous year, the business earned $0.26 earnings per share.
View Petmed Express' earnings history
.

How often does Petmed Express pay dividends? What is the dividend yield for Petmed Express?

Petmed Express declared a quarterly dividend on Monday, July 20th. Shareholders of record on Friday, July 31st will be paid a dividend of $0.28 per share on Friday, August 7th. This represents a $1.12 dividend on an annualized basis and a yield of 3.51%. The ex-dividend date of this dividend is Thursday, July 30th.
View Petmed Express' dividend history
.

What price target have analysts set for PETS?

2 brokers have issued 1 year price targets for Petmed Express' shares. Their forecasts range from $20.00 to $31.00. On average, they expect Petmed Express' stock price to reach $25.50 in the next year. This suggests that the stock has a possible downside of 20.0%.
View analysts' price targets for Petmed Express
.

Has Petmed Express been receiving favorable news coverage?

Media stories about PETS stock have trended somewhat negative recently, InfoTrie reports. The research firm identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Petmed Express earned a daily sentiment score of -1.9 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future.
View the latest news about Petmed Express
.

Are investors shorting Petmed Express?

Petmed Express saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 6,060,000 shares, an increase of 7.8% from the June 15th total of 5,620,000 shares. Based on an average trading volume of 629,200 shares, the days-to-cover ratio is presently 9.6 days. Currently, 31.2% of the company's stock are sold short.
View Petmed Express' Current Options Chain
.

Who are some of Petmed Express' key competitors?

What other stocks do shareholders of Petmed Express own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Petmed Express investors own include Intel (INTC), AT&T (T), NVIDIA (NVDA), Alibaba Group (BABA), Gilead Sciences (GILD), Cisco Systems (CSCO), Netflix (NFLX), Verizon Communications (VZ), Micron Technology (MU) and Advanced Micro Devices (AMD).

Who are Petmed Express' key executives?

Petmed Express' management team includes the following people:
  • Mr. Menderes Akdag, CEO, Pres & Director (Age 58)
  • Mr. Bruce S. Rosenbloom, CFO & Treasurer (Age 50)
  • Ms. Alison Berges, Corp. Sec. & Gen. Counsel

What is Petmed Express' stock symbol?

Petmed Express trades on the NASDAQ under the ticker symbol "PETS."

Who are Petmed Express' major shareholders?

Petmed Express' stock is owned by many different retail and institutional investors. Top institutional investors include Robeco Institutional Asset Management B.V. (1.74%), ProShare Advisors LLC (1.19%), WINTON GROUP Ltd (1.12%), Principal Financial Group Inc. (0.75%), Raymond James Financial Services Advisors Inc. (0.65%) and Fisher Asset Management LLC (0.50%). Company insiders that own Petmed Express stock include Bruce S Rosenbloom, Gian Fulgoni, Menderes Akdag and Robert C Schweitzer.
View institutional ownership trends for Petmed Express
.

Which major investors are selling Petmed Express stock?

PETS stock was sold by a variety of institutional investors in the last quarter, including Hancock Whitney Corp, Cairn Investment Group Inc., North Star Investment Management Corp., Principal Financial Group Inc., Profit Investment Management LLC, Fisher Asset Management LLC, Wedge Capital Management L L P NC, and Smith Asset Management Group LP. Company insiders that have sold Petmed Express company stock in the last year include Bruce S Rosenbloom, Gian Fulgoni, and Menderes Akdag.
View insider buying and selling activity for Petmed Express
.

Which major investors are buying Petmed Express stock?

PETS stock was bought by a variety of institutional investors in the last quarter, including Robeco Institutional Asset Management B.V., ProShare Advisors LLC, Raymond James Financial Services Advisors Inc., Mackay Shields LLC, WINTON GROUP Ltd, SG Americas Securities LLC, Jennison Associates LLC, and UBS Group AG.
View insider buying and selling activity for Petmed Express
.

How do I buy shares of Petmed Express?

Shares of PETS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Petmed Express' stock price today?

One share of PETS stock can currently be purchased for approximately $31.88.

How big of a company is Petmed Express?

Petmed Express has a market capitalization of $646.27 million and generates $284.13 million in revenue each year. Petmed Express employs 187 workers across the globe.

What is Petmed Express' official website?

The official website for Petmed Express is www.1800petmeds.com.

How can I contact Petmed Express?

Petmed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The company can be reached via phone at 561-526-4444.

This page was last updated on 8/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.